Histone Deacetylase Inhibitor, Vorinostat, as an Enhancer of Gemcitabine Therapy for Resistant Pancreatic Tumors

被引：0
|
作者：
Green, L. J. [1 ]
Koshkina, N. [1 ]
Curley, S. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [21] Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
    Hrzenjak, Andelko
    Moinfar, Farid
    Kremser, Marie-Luise
    Strohmeier, Bettina
    Petru, Edgar
    Zatloukal, Kurt
    Denk, Helmut
    MOLECULAR CANCER, 2010, 9
  • [22] Mechanisms of tumour-selective apoptosis induced by the histone deacetylase inhibitor vorinostat
    Bolden, J. E.
    Shi, W.
    Smyth, G. K.
    Cluse, L. A.
    Johnstone, R. W.
    EJC SUPPLEMENTS, 2008, 6 (09): : 86 - 86
  • [23] Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
    Andelko Hrzenjak
    Farid Moinfar
    Marie-Luise Kremser
    Bettina Strohmeier
    Edgar Petru
    Kurt Zatloukal
    Helmut Denk
    Molecular Cancer, 9
  • [24] Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
    Kumagai, Takashi
    Wakimoto, Naoki
    Yin, Dong
    Gery, Sigal
    Kawamata, Norihiko
    Takai, Noriyuki
    Komatsu, Naoki
    Chumakov, Alexy
    Imai, Yasufumi
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 656 - 665
  • [25] Proof of concept study with the histone deacetylase inhibitor vorinostat in patients with resistant BRAFV600 mutated advanced melanoma
    Huijberts, S. C. F. A.
    Wang, L.
    Wilgenhof, S.
    Rosing, H.
    Nuijen, B.
    Beijnen, J. H.
    de Oliveira, R. Leite
    Bernards, R.
    Schellens, J. H. M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [26] Brief Report: Case Comparison of Therapy With the Histone Deacetylase Inhibitor Vorinostat in a Neonatal Calf Model of Pulmonary Hypertension
    Applegate, Tanya J.
    Krafsur, Greta M.
    Boon, June A.
    Zhang, Hui
    Li, Min
    Holt, Timothy N.
    Ambler, S. Kelly
    Abrams, Benjamin A.
    Gustafson, Daniel L.
    Bartels, Karsten
    Garry, Franklyn B.
    Stenmark, Kurt R.
    Brown, R. Dale
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [27] In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?
    Modesitt, Susan C.
    Parsons, Sarah J.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 351 - 357
  • [28] Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
    Samulitis, Betty K.
    Pond, Kelvin W.
    Pond, Erika
    Cress, Anne E.
    Patel, Hitendra
    Wisner, Lee
    Patel, Charmi
    Dorr, Robert T.
    Landowski, Terry H.
    CANCER BIOLOGY & THERAPY, 2015, 16 (01) : 43 - 51
  • [29] Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
    Marie Grøn Saelen
    Anne Hansen Ree
    Alexandr Kristian
    Karianne Giller Fleten
    Torbjørn Furre
    Helga Helseth Hektoen
    Kjersti Flatmark
    Radiation Oncology, 7
  • [30] Effect of histone deacetylase inhibitor (vorinostat) on new-onset diabetes induced by tacrolimus
    Bakhdar, Fatmah A.
    Kawy, Hala S. Abdel
    Magadmi, Rania M.
    El-Kordy, Eman A.
    Alamri, Abdulhakeem S.
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2023, 18 (01): : 9 - 18
12345